Named patient products

Stallergenes Greer believes one solution does not fit all patients, hence we provide patients with personalised treatment options that are tailored to their individual needs. We aim to offer a comprehensive portfolio of AIT treatments globally which allow patients and their physicians to determine the administration method that best meets the disease and lifestyle needs of the patient.

The Group’s allergen extracts cover a vast array of allergens. They can be produced in standardised form and can also be tailored to the specific needs of patients in terms of composition, concentration, and dosage.

These personalised solutions, known as named patient products (NPPs), are prepared according to the physician’s prescription and the patient profile using a stock solution obtained via the extraction of allergens (pollens, house dust mites, moulds, etc.).

Each NPP has its own biological activity and is prepared for the unique needs of an individual patient.


Spanning source materials, routes of administration, cutting-edge delivery mechanisms and finished products, Stallergenes Greer’s innovative diagnostic tools and allergen immunotherapy (AIT) solutions are designed to improve ease of access and treatment outcomes.

Stallergenes Greer works with healthcare professionals specialised in allergy and patients at each stage of an allergen immunotherapy treatment. Our natural allergen extracts mimic the diverse allergen exposure in real-life to test and treat patients with the right allergens1. All our AITs have proven carry-over effects after treatment cessation and can even prevent allergy worsening2-10.

Our interoperable portfolio, which covers a vast range of administration routes, is tailored to the needs of healthcare professionals and the needs and lifestyle of each individual. 

Food allergy


Palforzia® (powder to be consumed with semi-solid foods), for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut for patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. Use of Palforzia® may be continued in patients 18 years of age and older.

Palforzia® is not indicated for the emergency treatment of allergic reactions, including anaphylaxis, and must always be used in conjunction with a peanut-avoidant diet.

Respiratory allergy


Staloral® (oral solution), for the treatment of allergy involving rhinitis, conjunctivitis, rhino conjunctivitis or asthma (mild to moderate) of a seasonal or perennial nature, in adults and children (from the age of 5).

Actair®/ Orylmyte®/ Aitmyte® (tablet), for the treatment of house dust mite allergies involving rhinitis, with or without conjunctivitis, in adults and adolescents over the age of 12 (and under 12 years of age in certain territories).

Oralair®/ Aitgrys® (tablet), for the treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents, and children (above the age of 5). Oralair® is a fivegrass (cocksfoot, sweet vernal grass, rye grass, meadow grass, and timothy) mixture, which represents many of the natural exposure and sensitisation conditions of grass pollen allergic patients.


Alustal®, for the treatment of allergic rhinitis, allergic rhinoconjunctivitis or mild to moderate asthma in adults and children (from the age of 5).

Albey® venom, for the treatment of allergy to wasp, honeybee, and yellow jacket venoms.

Extracts and supplies

Stallergenes Greer manufactures a broad portfolio of allergen extracts and diagnostic tests.

Veterinary use

In the U.S., Stallergenes Greer offers a comprehensive range of allergen extracts and supplies for veterinary dermatologists to support the needs of their clients and pet patients.

Veterinary dermatologists are veterinarians that have specialised training in the management of allergic disease. They may use products from companies like Stallergenes Greer to compound named patient allergy products for dogs, cats, horses, and more.

Stallergenes Greer produces extracts of different strengths and formulations specifically for veterinary specialists.



Palforzia®: © 2023, Société des Produits Nestlé S.A. or its affiliates


1. Incorvaia C, et al. Clin Mol Allergy 2021;19:10
2. Voltolini S, et al. Curr Med Res Opin 2010;26:37–40
3. Wahn U, et al. Allergy 2019;74:594–604
4. Sablayrolles V, et al. Rev Fr Allergol 2012;52:311–6
5. Didier A, et al. Clin Transl Allergy 2015;5:1216. 
6. Devillier P, et al. Expert Rev Clin Immunol 2017;13:1199–2061 
7. Bozek A, et al. Adv Dermatol Allergol 2020;37:943–7
8. Bozek A, et al. Adv Dermatol Allergol 2020;XXXVII:943–7 
9. Bergmann KC, et al. J Allergy Clin Immunol 2014;133:1608–14
10. Des Roches A, et al. Allergy 1996;51:430–3


Last updated on: 31/10/2023

Cookies Management